Physician profile
Jay Lee
NPI 1053346858
$35,169.04
in general payments reported to CMS, 2019-2025
38 companies · $1,296 in 2025
The $1,296 reported for 2025 was more than what 76% of Cardiovascular Disease providers received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $19K · 2020: $919 · 2021: $1,904 · 2022: $2,683 · 2023: $1,261 · 2024: $7,800 · 2025: $1,296.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $6,461 · Food and Beverage: $3,896.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $6,461.16 |
| Food and Beverage | $3,896.11 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $17,650.98 | 2019-2024 | Xarelto |
| Boston Scientific Corporation | $4,440.90 | 2019-2025 | General - Therapies, Rhythmia Mapping System, General - Ep |
| Abbott Laboratories | $3,851.41 | 2019-2025 | Aveir, Agilis |
| Regeneron Pharmaceuticals, INC. | $3,511.72 | 2024 | Libtayo |
| Biosense Webster, INC. | $809.66 | 2019-2024 | Carto 3 |
| Novartis Pharmaceuticals Corporation | $661.99 | 2019-2025 | |
| Sanofi-Aventis U.S. LLC | $578.90 | 2019-2024 | |
| Atricure, INC. | $396.93 | 2019-2023 | |
| Pfizer INC. | $332.77 | 2019-2025 | |
| Edwards Lifesciences Corporation | $306.70 | 2023-2024 | Pascal, Evoque |
| Medtronic, INC. | $299.18 | 2022-2024 | Selectsecure, Micra, Na |
| Astellas Pharma US INC | $290.55 | 2021-2022 | |
| Cardiva Medical, INC. | $271.06 | 2020-2025 | Cardiva Vascade Mvp Vvcs 6-12f, Savvywire, Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Kestra Medical Technology Services, INC. | $243.78 | 2022-2025 | Assure Wcd |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $225.67 | 2019-2025 | Lifevest |
Show all 38 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abiomed | $143.05 | 2019-2025 | |
| Penumbra, INC. | $141.00 | 2021 | |
| Amgen INC. | $114.86 | 2019-2023 | Repatha |
| Acutus Medical, INC. | $109.79 | 2022 | |
| Biotronik INC. | $108.42 | 2025 | Pantera Leo, Nhancer Rx, Recross |
| Boehringer Ingelheim Pharmaceuticals, INC. | $107.00 | 2021-2024 | Jardiance |
| E.R. Squibb & Sons, L.L.C. | $63.57 | 2025 | Camzyos |
| Cvrx, INC. | $60.01 | 2022-2023 | Barostim Neo System |
| Cardiovascular Systems INC. | $56.64 | 2019-2021 | |
| Bardy Diagnostics, INC. | $50.42 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $50.22 | 2019-2023 | Farxiga |
| Philips North America LLC | $40.17 | 2022 | |
| Merck Sharp & Dohme LLC | $33.69 | 2024-2025 | Verquvo |
| Scpharmaceuticals INC. | $32.93 | 2024-2025 | |
| Ethicon US, LLC | $28.48 | 2025 | Vistaseal |
| Inari Medical, INC. | $27.70 | 2021 | |
| Portola Pharmaceuticals, LLC | $26.69 | 2019 | |
| Siemens Medical Solutions USA, INC. | $20.09 | 2022 | |
| Altathera Pharmaceuticals LLC | $19.95 | 2025 | Sotalol Hydrochloride |
| Novo Nordisk INC | $17.61 | 2024 | Ozempic |
| Medtronic Vascular, INC. | $17.16 | 2019 | |
| Amarin Pharma, INC. | $14.46 | 2020 | |
| Kowa Pharmaceuticals America, INC. | $12.93 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jay Lee listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.